Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The goal of this clinical trial is to assess the effectiveness of GS010, a gene therapy, in improving the visual outcome in participants with Leber Hereditary Optic Neuropathy (LHON) due to the G11778A ND4 mitochondrial mutation when vision loss is present for six months or less.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Selection Criteria:
Participants must meet all the following criteria at the Screening Visit (Visit 1) in order to be included into the study.
Inclusion Criteria:
Participants included in the study must satisfy all the following criteria at the Inclusion Visit (Visit 2).
Exclusion criteria
Non-Selection Criteria:
Participants who meet at least one of the following criteria at the Screening Visit (Visit 1) will not be included into the study.
Exclusion Criteria:
Participants who meet at least one of the following criteria at the Inclusion Visit (Visit 2) will not be included in the study.
Primary purpose
Allocation
Interventional model
Masking
39 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal